Search
for
Sort by
Research 781–810 of 1000+
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- How should postmenopausal androgen excess be evaluated?
- Treatment of Vitiligo With the 308-nm Xenon Chloride Excimer Laser
- Anagen effluvium
- Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
- Elevated Free Testosterone Levels in Women With Acne
- Associaton of Insulin Resistance Linked Diseases and Hair Loss in Elderly Men. Finnish Population-based Study
- Adverse Reactions to Oral Retinoids An Update
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Oral Retinoids in Dermatology
- Comparitive Effectiveness and Finasteride <i>Vs Serenoa Repens</i> in Male Androgenetic Alopecia: A Two-Year Study
- TOXIC EPIDERMAL NECROLYSIS
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Emotion Dysregulation of Women with Premenstrual Syndrome
- Biochemical Roles of Testosterone and Epitestosterone to 5α-Reductase as Indicators of Male-Pattern Baldness
- Idiopathic Hirsutism*
- Sustained release of dermal papilla-derived extracellular vesicles from injectable microgel promotes hair growth
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Mitoxantrone
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Effective medical treatment for common baldness in women
- Toxicologic studies with the hypotensive agent minoxidil
- Evidence-based approach to cutaneous hyperandrogenism in women
- Congenital hypotrichosis due to short anagen
- Subacute cutaneous lupus erythematosus presenting as erythroderma
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Update on the dermatologic use of systemic glucocorticosteroids
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess